Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

Journal Title: Iranian journal of diabetes and obesity (IJDO) - Year 2024, Vol 16, Issue 3

Abstract

Objective: The objective of the present analysis was to compare the effect of these two treatment regimens (Novomix insulin twice or thrice-daily versus once-daily insulin glargine plus twice or thrice-daily insulin aspart) on glycemic control in Iranian patients with T2DM. Materials and Methods: This cross-sectional study was conducted for one year on people with type 2 diabetes referred to Yazd Medical Research Center. Glycemic control (HbA1C, FBG, and 2hPP) from baseline (week 0) to 24 -48 weeks were recorded in the electronic file of patients receiving Novomix insulin twice or thrice daily. These profiles were compared to those of patients receiving once-daily insulin glargine plus twice or thrice-daily insulin aspart (according to each meal). P< 0.05 was considered as a significant level. Results: Based on the finding, both treatment groups demonstrated significant reductions in FBG, 2hPP, and HbA1c from baseline to the study endpoint (weeks 24 and 48) (P< 0.05 for all comparisons). However, the changes in HbA1c, FBG, and 2hPP levels compared to the baseline level during the study were not significant between the two groups. Conclusion: The insulin glargine regime is effective in reducing HbA1C-FBS-2HPP compared to aspart and Novomix, but no significant difference was seen between the two mentioned regimes. It is recommended to observe more effectiveness and achieve more efficient and reliable results of the studies.

Authors and Affiliations

Seyyed Hossein Mirtorabi,Roghaye Razavi,Roghaye Mirjalili,Nasim Namiranian,Mozhgan Modarresi,Reyhaneh Azizi,

Keywords

Related Articles

Correlation between Cytochrome P450, 5-alpha Reductase, and Androgen Receptor Levels in Patients with Type 2 Diabetes Mellitus

Objective: Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases. The CYP450 plays an important role in the biosynthesis of steroid hormones and the hormonal activity is mediated by the androgen rece...

Effectiveness of Acceptance and Commitment Based Group Therapy with the Islamic Approach on Diabetes Control and Increasing Self-Care Behaviors in Patients with Type II Diabetes in Yazd province.

Objective: The purpose of this study was to investigate the effectiveness of acceptance and commitment based group therapy (ACT) with the Islamic approach to diabetes control, increasing self-care behaviors in patients w...

Impact of COVID-19 Pandemic and Lockdown Measures on the Nutrition Plan Service Cohort

Objective: This study analyses the patientschr('39') factors can influence the attitude to follow or not the therapeutic weight-loss plan after national lockdown measures adopted from March 2020 to May 2020. Materials a...

Identification of Factors Related to Sexual Dysfunction in Type 2 Diabetic Women

Objective: Type 2 diabetes mellitus (T2DM) is one of the most common metabolic diseases among women. Sexual dysfunction (SD) is a complication in patients with T2DM that has received less attention among women than men....

Correlation between Circulating Endothelial Progenitor Cell Markers, Vitamin D, and Iron Levels in Diabetic Nephropathy

Objective: Circulating endothelial progenitor cells (EPCs) play an essential role in endothelial repair and neovascularization. Vitamin D deficiency may contribute to EPC depletion and endothelial dysfunction in patients...

Download PDF file
  • EP ID EP743457
  • DOI -
  • Views 6
  • Downloads 0

How To Cite

Seyyed Hossein Mirtorabi, Roghaye Razavi, Roghaye Mirjalili, Nasim Namiranian, Mozhgan Modarresi, Reyhaneh Azizi, (2024). Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Iranian journal of diabetes and obesity (IJDO), 16(3), -. https://europub.co.uk/articles/-A-743457